Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 21 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8410274

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  2. US 8410112

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  3. US 8410132

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  4. US 8410133

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  5. US 8404849

    Processes for producing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  6. US 8404852

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  7. US 8399479

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  8. US 8399615

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  9. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  10. US 8399458

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  11. US 8394803

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  12. US 8394952

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  13. US 8389734

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  14. US 8389727

    Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  15. US 8383858

    Processes and intermediates for preparing steric compounds

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  16. US 8383633

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  17. US 8378124

    Preparation of protected alpha-keto beta-amino esters and amides

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  18. US 8377926

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  19. US 8372846

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  20. US 8372843

    Quinolines useful as modulators of ION channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  21. US 8372835

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  22. US 8372850

    Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  23. US 8372873

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  24. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted